Queen Elizabeth II Health Sciences Centre, in Halifax, Nova Scotia, Canada, is a large teaching hospital and Level 1 Trauma Centre affiliated with Dalhousie University. The QEII cares for adult patients. Pediatric patients within the region are cared for at the IWK Health Centre.

During the past decade, Queen Elizabeth II Health Sciences Centre conducted 227 clinical trials. In the 10-year time frame, 227 clinical trials started and 121 clinical trials were completed, i.e. on average, 53.3% percent of trials that started reached the finish line to date. In the past 5 years, 83 clinical trials started and 69 clinical trials were completed. i.e. 83.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queen Elizabeth II Health Sciences Centre" #1 sponsor was "Nova Scotia Health Authority" with 37 trials, followed by "NCIC Clinical Trials Group" with 30 trials sponsored, "Canadian Cancer Trials Group" with 25 trials sponsored, "Pfizer" with 15 trials sponsored and "National Cancer Institute (NCI)" with 15 trials sponsored. Other sponsors include 370 different institutions and companies that sponsored additional 200 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Elizabeth II Health Sciences Centre" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 54 trials as a collaborator, "National Cancer Institute (NCI)" with 14 trials as a collaborator, "Nova Scotia Health Authority" with 13 trials as a collaborator, "SWOG Cancer Research Network" with 12 trials as a collaborator and "Dalhousie University" with 10 trials as a collaborator. Other collaborators include 410 different institutions and companies that were collaborators in the rest 251 trials.

According to Clinical.Site data, the most researched conditions in "Queen Elizabeth II Health Sciences Centre" are "Multiple Myeloma" (23 trials), "Atrial Fibrillation" (18 trials), "Prostate Cancer" (17 trials), "Heart Failure" (16 trials) and "Breast Cancer" (13 trials). Many other conditions were trialed in "Queen Elizabeth II Health Sciences Centre" in a lesser frequency.

Most popular intervention types in "Queen Elizabeth II Health Sciences Centre" are "Drug" (296 trials), "Other" (71 trials), "Device" (69 trials), "Procedure" (49 trials) and "Biological" (44 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (59 trials), "Dexamethasone" (18 trials), "Rituximab" (13 trials), "Bortezomib" (10 trials) and "Laboratory Biomarker Analysis" (9 trials). Other intervention names were less common.

The vast majority of trials in "Queen Elizabeth II Health Sciences Centre" are 438 trials for "All" genders, 29 trials for "Male" genders and 28 trials for "Female" genders.

Currently, there are 146 active trials in "Queen Elizabeth II Health Sciences Centre". 5 are not yet recruiting, 70 are recruiting, 65 are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were 274 completed trials in Queen Elizabeth II Health Sciences Centre, 3 suspended trials, and 37 terminated clinical trials to date.

Out of the total trials that were conducted in Queen Elizabeth II Health Sciences Centre, 25 "Phase 1" clinical trials were conducted, 116 "Phase 2" clinical trials and 175 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 36 trials, and there were also 98 trials that are defined as “Not Applicable".

Queen Elizabeth II Health Sciences Centre has several departments that took part in Clinical trials: "Nova Scotia Rehabilitation Centre" - 15 trials, "Nova Scotia Cancer Centre" - 101 trials, "CDHA - Pain Management Unit" - 2 trials